4.5 Article

Evolution of the Incidence of Collagenous Colitis and Lymphocytic Colitis in Terrassa, Spain: A Population-based Study

Journal

INFLAMMATORY BOWEL DISEASES
Volume 17, Issue 4, Pages 1015-1020

Publisher

WILEY-BLACKWELL
DOI: 10.1002/ibd.21438

Keywords

collagenous colitis; lymphocytic colitis; microscopic colitis; epidemiology; incidence

Funding

  1. Fondo de Investigaciones Sanitarias [PI06/1577]
  2. Spanish Ministry of Health (Health Institute Carlos III)

Ask authors/readers for more resources

Background: Previous studies suggest an increase in the incidence rate of microscopic colitis in recent decades. The aim was to evaluate changes in the population-based incidence rate of microscopic colitis and its subtypes over time in Terrassa, Spain. Methods: This was a prospective study during the period 2004-2008, with a comparison of data from the period 1993-1997. The catchment area was a mixed rural-urban type, with nearly 290,000 inhabitants. All patients with nonbloody chronic diarrhea referred for a diagnostic colonoscopy were included. Multiple biopsy specimen samples were obtained when the macroscopic appearance of the colonic mucosa was normal to rule out microscopic colitis. Crude and adjusted incidence rates based on either the year of diagnosis or the date of onset of symptoms were calculated. Results: Forty patients with collagenous colitis (CC) and 32 with lymphocytic colitis (LC) were identified. The mean annual incidence of CC and LC based on the year of onset of symptoms was 2.6/10(5) inhabitants (95% confidence interval [CI], 1.9-3.3), and 2.2/10(5) inhabitants (95% CI, 1.5-3.0), respectively. Incidence rates for CC based on the year of onset of symptoms were significantly higher in the period 2004-2008 than in 1993-1997 (2.6 versus 1.1/10(5); P = 0.012). The increase in CC incidence was more marked in women (P = 0.047) than in men (P = 0.19). Conclusions: The annual incidence of CC in Terrassa increased over time, mainly in women. Nevertheless, the rates were much lower than those observed in northern Europe, suggesting that there is a north-south difference in the incidence of microscopic colitis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Chronic pancreatitis for the clinician. Part 2: Treatment and follow-up. Interdisciplinary Position Paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees

Xavier Molero, Juan Ramon Ayuso, Joaquim Balsells, Jaume Boadas, Juli Busquets, Anna Casteras, Mar Concepcion, Miriam Cuatrecasas, Gloria Fernandez Esparrach, Esther Fort, Francisco Garcia Borobia, Angels Gines, Lucas Ilzarbe, Carme Loras, Miquel Masachs, Xavier Merino, Jorge J. Olsina, Valenti Puig-Divi, Silvia Salord, Teresa Serrano, Eva Cristina Vaquero

Summary: Chronic pancreatitis is a serious condition that affects quality of life and is associated with high morbidity, complications, and mortality. The cost of healthcare for this condition is also high. Current guidelines for treatment are often based on limited scientific evidence, leading to vague recommendations. This position paper aims to provide clear position statements for clinicians based on a review of published literature and expert consensus, with the goal of promoting standardized terminology and rational diagnostic/therapeutic approaches.

GASTROENTEROLOGIA Y HEPATOLOGIA (2022)

Article Gastroenterology & Hepatology

Chronic pancreatitis for the clinician. Part 1: Etiology and diagnosis. Interdisciplinary position paper of the Societat Catalana de Digestologia and the Societat Catalana de Pancrees

Xavier Molero, Juan Ramon Ayuso, Joaquim Balsells, Jaume Boadas, Juli Busquets, Anna Casteras, Mar Concepcion, Miriam Cuatrecasas, Gloria Fernandez Esparrach, Esther Fort, Francisco Garcia Borobia, Angel Gines, Lucas Ilzarbe, Carme Loras, Miquel Masachs, Xavier Merino, Jorge J. Olsina, Valenti Puig-Divi, Silvia Salord, Teresa Serrano, Eva Cristina Vaquero

Summary: Chronic pancreatitis is a complex disease with diverse etiological factors and variable clinical presentations. Treatment options are wide-ranging, but recommendations are often vague or weak. This series of position papers aims to provide defined positions for clinicians based on updated research and expert consensus, with the goal of promoting the use of common terminology and rational diagnostic/therapeutic approaches.

GASTROENTEROLOGIA Y HEPATOLOGIA (2022)

Review Nutrition & Dietetics

Carbohydrate Maldigestion and Intolerance

Fernando Fernandez-Banares

Summary: This review summarizes the recent advances in the possible role of carbohydrate maldigestion and dietary outcomes in patients with functional bowel disease. It found that there are no differences in the frequency of sugar malabsorption between patients with irritable bowel disease (IBS) and healthy controls, but the severity of symptoms after a sugar challenge is higher in patients. A low FODMAP diet is an effective treatment for global symptoms and abdominal pain in IBS.

NUTRIENTS (2022)

Review Gastroenterology & Hepatology

Endoscopic Stenting in Crohn's Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes

Saurabh Chandan, Banreet S. Dhindsa, Shahab R. Khan, Smit Deliwala, Lena L. Kassab, Babu P. Mohan, Ojasvini C. Chandan, Carme Loras, Bo Shen, Gursimran S. Kochhar

Summary: Endoscopic stenting in CD-related strictures is a safe technique with limited clinical success. Post-procedure abdominal pain and proximal stent migration are common adverse events reported.

INFLAMMATORY BOWEL DISEASES (2023)

Article Gastroenterology & Hepatology

Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollon, Jose Miguel Arbones-Mainar, Berta Caballol, Javier P. Gisbert, Montserrat Rivero, Eugenia Sanchez-Rodriguez, Lara Arias Garcia, Ana Gutierrez Casbas, Olga Merino, Lucia Marquez, Viviana Laredo, Maria Dolores Martin-Arranz, Pilar Lopez Serrano, Sabino Riestra Menendez, Carlos Gonzalez-Munoza, Luisa de Castro Parga, Marta Calvo Moya, Esteban Fuentes-Valenzuela, Maria Esteve, Marisa Iborra, Miguel Dura Gil, Manuel Barreiro-De Acosta, Rufo Humberto Lorente-Poyatos, Noemi Mancenido, Margalida Calafat, Iago Rodriguez-Lago, Jordi Guardiola Capo, Maria Antonia Payeras, Victor Jair Morales Alvarado, Carlos Tardillo, Luis Bujanda, Jose Fernando Munoz-Nunez, Yolanda Ber Nieto, Fernando Bermejo, Pedro Almela, Merce Navarro-Llavat, Pilar Martinez Montiel, Cristina Rodriguez Gutierrez, Manuel Van Domselaar, Eva Sese, Teresa Martinez Perez, Elena Ricart, Maria Chaparro, Maria Jose Garcia, Antonio Lopez-Sanroman, Beatriz Sicilia, Beatriz Orts, Alicia Lopez-Garcia, Eduardo Martin-Larraz, Jose Lazaro Perez-Calle, Ruth de Francisco, Esther Garcia-Planella, Eugeni Domenech, Santiago Garcia-Loper

Summary: Ustekinumab shows similar effectiveness in elderly patients with CD as it does in non-elderly patients. The safety profile is also similar, except for a higher rate of de novo neoplasms in elderly patients.

JOURNAL OF CROHNS & COLITIS (2023)

Article Gastroenterology & Hepatology

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Laurent Peyrin-Biroulet, Jean-Francois Rahier, Julien Kirchgesner, Vered Abitbol, Sebastian Shaji, Alessandro Armuzzi, Konstantinos Karmiris, Javier P. Gisbert, Peter Bossuyt, Ulf Helwig, Johan Burisch, Henit Yanai, Glen A. Doherty, Fernando Magro, Tamas Molnar, Mark Lowenberg, Jonas Halfvarson, Edyta Zagorowicz, Helene Rousseau, Cedric Baumann, Filip Baert, Laurent Beaugerie

Summary: The I-CARE study aims to evaluate the benefit-risk ratio of current therapies in IBD patients. It collected data from 10,206 patients and observed the treatment risks of anti-tumor necrosis factor and other biologic therapies, particularly the risks of cancer/lymphoma and serious infections. The results showed that different treatment regimens had varying effects on patients, and further research is needed to assess specific risks.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Geriatrics & Gerontology

Sensogenomics of music and Alzheimer's disease: An interdisciplinary view from neuroscience, transcriptomics, and epigenomics

Laura Navarro, Alberto Gomez-Carballa, Sara Pischedda, Julian Montoto-Louzao, Sandra Viz-Lasheras, Alba Camino-Mera, Thomas Hinault, Federico Martinon-Torres, Antonio Salas

Summary: This study systematically reviewed the state-of-the-art of neuroscience and cognitive sciences research on music and Alzheimer's disease (AD) and found that music has beneficial effects on patients with neurodegenerative diseases, especially in memory and cognition. Transcriptomic and epigenomic data analysis also revealed connections between music-related genes and AD. These findings provide a new roadmap for genetic research and musical interventions in AD and other neurodegenerative conditions.

FRONTIERS IN AGING NEUROSCIENCE (2023)

Article Gastroenterology & Hepatology

Endoscopic removal of lumen-apposing metal stents - risk factors for stent embedment, complex removals, and adverse events: analysis from a multicenter prospective case series

Sergio Bazaga, Francisco Javier Garcia-Alonso, Jose Ramon Aparicio Tormo, Belen Martinez Moreno, Vicente Sanchiz, Carles Suria, Albert Garcia-Sumalla, Joan B. Gornals, Carlos Chavarria, Carme Loras, Francisco Jose Garcia-Fernandez, Alvaro Teran, Enrique Vazquez-Sequeiros, Rafael Pedraza Sanz, Leticia Perez-Carazo, Jose Carlos Subtil, Antonio Perez-Millan, Francisco Uceda Porta, Victoria Busto Bea, Carlos de la Serna-Higuera, Isabel Pinto Garcia, Juan Colan-Hernandez, Carlos Huertas, Carlos Guarner-Argente, Manuel Perez-Miranda

Summary: This study aimed to comprehensively assess the feasibility and safety of removing LAMS. The results showed that LAMS removal is safe and mostly requires basic endoscopic techniques. Referral to advanced endoscopy units should be considered for stents with known embedment or long indwell times, which may require more technically demanding procedures.

ENDOSCOPY (2023)

Article Gastroenterology & Hepatology

Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study

Francesc Bas-Cutrina, Carme Loras, Albert Pardo, Raquel Ballester-Clau, Carlos Huertas, Carlos Guarner-Argente, Juan Colan-Hernandez, Claudia F. Consiglieri, Xavi Andujar, Ferran Gonzalez-Huix, Magdalena Vilanova-Serra, Laura Pardo-Grau, Sandra Maisterra, Pablo Ruiz-Ramirez, Albert Garcia-Sumalla, Cristian Tebe, Sebastia Videla, Joan B. Gornals

Summary: Endoscopic band ligation (EBL) combined with single-incision needle-knife (SINK) biopsy sampling appears to have a positive impact on the management of small gastrointestinal subepithelial tumors (SETs), particularly in SETs with a diameter of ≤10 mm.

GASTROINTESTINAL ENDOSCOPY (2023)

Biographical-Item Gastroenterology & Hepatology

In memory of Dr. Fernando Fernandez-Baares (1958-2023)

Albert Martin-Cardona, Anna Carrasco, Maria Esteve

GASTROENTEROLOGIA Y HEPATOLOGIA (2023)

Article Gastroenterology & Hepatology

Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients

Annalisa Schiepatti, Stiliano Maimaris, Suneil A. Raju, Olivia L. Green, Giulia Mantica, Amelie Therrien, David Flores-Marin, Justin Linden, Fernando Fernandez-Banares, Maria Esteve, Daniel Leffler, Federico Biagi, David S. Sanders

Summary: Objective Persistent villous atrophy (pVA), a condition where the intestinal lining remains damaged despite a gluten-free diet, has unclear significance in coeliac disease (CD). This study aimed to investigate the relationship between pVA and long-term outcomes and develop a scoring system to identify patients at risk of pVA. The results showed that patients with pVA had increased risk of complications and mortality. A 5-point score was developed to classify patients into low, intermediate, and high risk categories. Age at diagnosis, classic pattern of CD, lack of clinical response to GFD, and poor GFD adherence were identified as predictors for pVA.
Article Medicine, Research & Experimental

Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial

Carme Loras, Pablo Ruiz-Ramirez, Juan Romero, Xavier Andujar, Josep Bargallo, Esther Bernardos, Marta Maia Bosca-Watts, Carlo Brugiotti, Eduard Brunet, David Busquets, Elena Cerrillo, Francisco Javier Cortina, Juan Antonio Diaz-Milanes, Carmen Duenas, Ramon Farres, Thomas Golda, Ferran Gonzalez-Huix, Joan B. Gornals, Jordi Guardiola, David Julia, Alba Lira, Jordina Llao, Miriam Manosa, Ingrid Marin, Monica Millan, David Monfort, David Moro, Josep Mullerat, Merce Navarro, Francisco Perez Roldan, Eva Pijoan, Vicente Pons, Jose Reyes, Maria Rufas, Empar Sainz, Vicente Sanchiz, Anna Serracant, Eva Sese, Cristina Soto, Jose Troya, Natividad Zaragoza, Cristian Tebe, Marta Paraira, Emma Sudria-Lopez, Vicenc Mayor, Fernando Fernandez-Banares, Maria Esteve

Summary: This study aims to compare the therapeutic efficacy of endoscopic and surgical treatments for de novo stenosis in Crohn's disease. The study will include 40 patients who will be randomly assigned to either the endoscopic or surgical treatment group, and their quality of life and treatment outcomes will be evaluated at 1-year follow-up.

TRIALS (2023)

Article Biotechnology & Applied Microbiology

Chatting with ChatGPT to learn about safety of COVID-19 vaccines - A perspective

Antonio Salas, Irene Rivero-Calle, Federico Martinon-Torres

Summary: Vaccine hesitancy is considered a top global health threat by the WHO. This study investigates the ability of the AI chatbot ChatGPT to generate opinions on vaccine hesitancy by examining its response to prevalent false information, contraindications, and myths about vaccine safety circulating on the internet. The findings suggest that while ChatGPT's default responses may be incomplete, they are generally satisfactory and have the potential to guide users towards scientifically aligned information, though it cannot replace experts or scientific evidence itself.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Half of the patients with subepithelial tumors present borderline or pathologic anxiety-distress and carcinophobia: a multicenter cohort study

Francesc Bas-Cutrina, Anna Casellas-Grau, Sebastia Videla, Carme Loras, Xavi Andujar, Francisco Luis Gil, Maica Galan, Fernando Fernandez-Aranda, Joao Carmezim, Joan B. Gornals

Summary: This study aimed to evaluate anxiety and carcinophobia in patients referred to specialized outpatient clinics for evaluation and treatment of minor nonspecific gastrointestinal sub-epithelial lesions. The study found that almost half of the patients presented with anxiety and/or carcinophobia, and specific associations with anxiety and fears were detected.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2023)

Article Pharmacology & Pharmacy

Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection

Alberto Gomez-Carballa, Guillermo Albericio, Julian Montoto-Louzao, Patricia Perez, David Astorgano, Irene Rivero-Calle, Federico Martinon-Torres, Mariano Esteban, Antonio Salas, Juan Garcia-Arriaza

Summary: This study investigates the molecular mechanism of COVID-19 vaccines and their effects on the host response to SARS-CoV-2 infection. The findings suggest that one dose of MVA-S provides partial protection while two doses provide full protection against infection. The study also identifies key genes involved in viral control and immune response.

ANTIVIRAL RESEARCH (2023)

No Data Available